2.

General characteristics of 74 patients

Characteristics		Number (%) Median (95%CI)
CI: Confidence interval; SD: Standard deviation; HAD: HangAm-Dan; wks : weeks.
Gender	Female : Male	21 (28.4) : 53 (71.6)
Age	Mean±SD	63.3±11.5
Stage	Ⅲb : Ⅳ	8 (10.8) : 66 (89.2)
Duration from diagnosis to HAD treatment		9.0 months (5.0-13.0)
Duration of HAD treatment	< 4wks	1.0 month (0.5-1.5) 31 (41.9)
	≥4wks	43 (58.1)
Combination with chemotherapy during HAD treatment	Yes	44 (59.5)
	No	30 (40.5)
HAD group	Age (Mean±SD)	67.7±11.2 4
	Gender (Female : Male)	4 (13.3) : 26 (86.7)
	Stage (Ⅲb : Ⅳ)	4 (13.3) : 26 (86.7)
Combined group	Age (Mean±SD)	60.2±10.2
	Gender (Female : Male)	17 (38.6) : 27 (61.4)
	Stage (Ⅲb : Ⅳ)	4 (9.1) : 40 (90.9)